214 related articles for article (PubMed ID: 17328047)
1. Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction.
Brown DA; Moore J; Johnen H; Smeets TJ; Bauskin AR; Kuffner T; Weedon H; Milliken ST; Tak PP; Smith MD; Breit SN
Arthritis Rheum; 2007 Mar; 56(3):753-64. PubMed ID: 17328047
[TBL] [Abstract][Full Text] [Related]
2. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
[TBL] [Abstract][Full Text] [Related]
3. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
Ballara S; Taylor PC; Reusch P; Marmé D; Feldmann M; Maini RN; Paleolog EM
Arthritis Rheum; 2001 Sep; 44(9):2055-64. PubMed ID: 11592367
[TBL] [Abstract][Full Text] [Related]
4. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
Park MC; Chung SJ; Park YB; Lee SK
Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
[TBL] [Abstract][Full Text] [Related]
5. Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Skowronski J; Cylwik JP; Cylwik B; Chwiecko J
J Rheumatol; 2005 Sep; 32(9):1666-72. PubMed ID: 16142858
[TBL] [Abstract][Full Text] [Related]
6. Soluble LILRA3, a potential natural antiinflammatory protein, is increased in patients with rheumatoid arthritis and is tightly regulated by interleukin 10, tumor necrosis factor-alpha, and interferon-gamma.
An H; Chandra V; Piraino B; Borges L; Geczy C; McNeil HP; Bryant K; Tedla N
J Rheumatol; 2010 Aug; 37(8):1596-606. PubMed ID: 20595277
[TBL] [Abstract][Full Text] [Related]
7. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood expression profiles of bone morphogenetic proteins, tumor necrosis factor-superfamily molecules, and transcription factor Runx2 could be used as markers of the form of arthritis, disease activity, and therapeutic responsiveness.
Grcevic D; Jajic Z; Kovacic N; Lukic IK; Velagic V; Grubisic F; Ivcevic S; Marusic A
J Rheumatol; 2010 Feb; 37(2):246-56. PubMed ID: 20008919
[TBL] [Abstract][Full Text] [Related]
9. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy.
Baeten D; Kruithof E; De Rycke L; Boots AM; Mielants H; Veys EM; De Keyser F
Arthritis Res Ther; 2005; 7(2):R359-69. PubMed ID: 15743484
[TBL] [Abstract][Full Text] [Related]
10. Synovial vascular patterns and angiogenic factors expression in synovial tissue and serum of patients with rheumatoid arthritis.
Salvador G; Sanmartí R; Gil-Torregrosa B; García-Peiró A; Rodríguez-Cros JR; Cañete JD
Rheumatology (Oxford); 2006 Aug; 45(8):966-71. PubMed ID: 16490752
[TBL] [Abstract][Full Text] [Related]
11. Synovial tissue heterogeneity in rheumatoid arthritis in relation to disease activity and biomarkers in peripheral blood.
van Baarsen LG; Wijbrandts CA; Timmer TC; van der Pouw Kraan TC; Tak PP; Verweij CL
Arthritis Rheum; 2010 Jun; 62(6):1602-7. PubMed ID: 20178127
[TBL] [Abstract][Full Text] [Related]
12. Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype.
Thurlings RM; Wijbrandts CA; Mebius RE; Cantaert T; Dinant HJ; van der Pouw-Kraan TC; Verweij CL; Baeten D; Tak PP
Arthritis Rheum; 2008 Jun; 58(6):1582-9. PubMed ID: 18512774
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: a prospective study in 154 consecutive patients.
Baeten D; Kruithof E; De Rycke L; Vandooren B; Wyns B; Boullart L; Hoffman IE; Boots AM; Veys EM; De Keyser F
Arthritis Rheum; 2004 Sep; 50(9):2931-41. PubMed ID: 15457462
[TBL] [Abstract][Full Text] [Related]
14. Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-alpha-elicited endothelial activation.
Di Comite G; Rossi CM; Marinosci A; Lolmede K; Baldissera E; Aiello P; Mueller RB; Herrmann M; Voll RE; Rovere-Querini P; Sabbadini MG; Corti A; Manfredi AA
J Leukoc Biol; 2009 Jan; 85(1):81-7. PubMed ID: 18832606
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
[TBL] [Abstract][Full Text] [Related]
16. Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis.
Schmidt M; Hartung R; Capellino S; Cutolo M; Pfeifer-Leeg A; Straub RH
Arthritis Rheum; 2009 Oct; 60(10):2913-22. PubMed ID: 19790073
[TBL] [Abstract][Full Text] [Related]
17. Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.
van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Rustenburg F; Baggen JM; Verweij CL; Tak PP
Ann Rheum Dis; 2008 Apr; 67(4):563-6. PubMed ID: 18042642
[TBL] [Abstract][Full Text] [Related]
18. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
[TBL] [Abstract][Full Text] [Related]
19. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis.
Liao H; Wu J; Kuhn E; Chin W; Chang B; Jones MD; O'Neil S; Clauser KR; Karl J; Hasler F; Roubenoff R; Zolg W; Guild BC
Arthritis Rheum; 2004 Dec; 50(12):3792-803. PubMed ID: 15593230
[TBL] [Abstract][Full Text] [Related]
20. Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity.
Galligan CL; Baig E; Bykerk V; Keystone EC; Fish EN
Genes Immun; 2007 Sep; 8(6):480-91. PubMed ID: 17568789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
